- Bay Area Times
- Posts
- Eli Lilly strikes $2.75B deal with Insilico for AI-developed drugs
Eli Lilly strikes $2.75B deal with Insilico for AI-developed drugs
Bay Area Times
March 30, 2026
Brought to you by:
Top stories today:
- Eli Lilly strikes $2.75B deal with Insilico for AI-developed drugs
- Meta to unveil Ray-Ban smart glasses for prescription wearers this week
- xAI loses last cofounder Ross Nordeen, ending Elon’s founding team
- Physical Intelligence said to seek $1B round at $11B+ valuation
- Kalshi secures margin trading license to attract institutional investors
- Meta’s Avocado seen testing multiple AI variants, including 9B model
0. Data and calendar
All values as of 6 AM ET / 3 AM PT, other than S&P500 and NASDAQ close (4 PM ET / 1 PM PT).
All times are ET.
Listen to our AI-generated podcast summarizing today’s newsletter (beware of hallucinations):
1. Eli Lilly strikes $2.75B deal with Insilico for AI-developed drugs
Insilico Medicine shares closed +3% Mon. after rising as much as 15%, their strongest intraday rally in ~2 months:
Insilico will receive $15M upfront, with the rest tied to regulatory and commercial milestones.
The deal also includes royalties on future sales.
Insilico has developed at least 28 drugs using GenAI, ~50% of them are already in clinical stages, CEO Alex Zhavoronkov said.
2023: Eli Lilly and Insilico signed an AI software licensing deal.
Insilico develops AI outside China but conducts early preclinical work there.
Watch the on-demand webinar to see how Slackbot lives in the flow of work, already understanding your conversations, files, and people—delivering answers and actions that are relevant and personalized to you.
Learn from real Slack customers, like Engine and Asymbl, as they share how Slackbot finds answers, analyzes documents, schedules meetings, creates content, and orchestrates specialized agents to execute complex workflows.
See contextual intelligence in action as Slackbot moves work forward by respecting your permissions and working with the tools you trust.
*Sponsored.
3. Meta said to launch Ray-Ban smart glasses for prescription wearers this week
Rectangular and rounded styles are expected.
Codenamed Scriber and Blazer, they are not next-gen Meta smart glasses.
“[B]illions of people wear glasses or contacts,” Mark Zuckerberg said, hinting at a broader push into prescription wearers.
4. xAI loses last cofounder Ross Nordeen, ending Elon’s founding team
Nordeen has also lost the badge on X that identifies him as an xAI employee:
